ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Viral Immunity
Australian State/Territory : ACT
Clear All
Filter by Field of Research
Medical Virology (6)
Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies) (2)
Innate Immunity (2)
Medical Parasitology (2)
Animal Immunology (1)
Biochemistry and Cell Biology (1)
Clinical sciences not elsewhere classified (1)
Infectious Diseases (1)
Medical Microbiology (1)
Medical and Health Sciences (1)
Medical and Health Sciences not elsewhere classified (1)
Respiratory Diseases (1)
Virology (1)
Zoology (1)
Filter by Socio-Economic Objective
Blood Disorders (1)
Disease Distribution and Transmission (incl. Surveillance and Response) (1)
Immune System and Allergy (1)
Infectious Diseases (1)
Livestock Raising not elsewhere classified (1)
Public Health (excl. Specific Population Health) not elsewhere classified (1)
Filter by Funding Provider
National Health and Medical Research Council (15)
Australian Research Council (2)
Filter by Status
Closed (17)
Filter by Scheme
Project Grants (6)
NHMRC Project Grants (5)
ARC Future Fellowships (1)
Career Development Fellowships (1)
Discovery Projects (1)
NHMRC Strategic Awards (1)
Programs (1)
Targeted Calls (1)
Filter by Country
Australia (17)
Filter by Australian State/Territory
ACT (17)
NSW (6)
QLD (5)
WA (4)
TAS (1)
  • Researchers (1)
  • Funded Activities (17)
  • Organisations (1)
  • Funded Activity

    Arbovirus Activation And Modulation Of NLRP3 Inflammasome

    Funder
    National Health and Medical Research Council
    Funding Amount
    $779,720.00
    Summary
    This project aims to establish how mosquito borne viruses such as Ross River and dengue viruses interacts with the human host to cause disease, including how the virus evades the host’s immune response to persist and cause disease for prolonged periods. Knowing how differences in the virus and the host’s immune system interplay to cause asymptomatic to severely disabling disease will assist in devising new treatments and prevention programs to lessen the impact of these diseases in Australia.
    More information
    Funded Activity

    A NOVEL MOUSE MODEL TO INVESTIGATE THE MECHANISMS OF VIRUS-INDUCED ARTHRITIS

    Funder
    National Health and Medical Research Council
    Funding Amount
    $336,000.00
    Summary
    We have developed a novel animal model by which to study arthritic disease caused by insect-transmitted viruses known as arboviruses. The existence of this model and novel reagents provides an excellent opportunity to further explore the basic mechanisms of infectious disease in a complete functioning animal, rather than specific cultured cells. The study will use modern approaches in molecular and cellular biology to achieve this goal. The production by our immune systems of soluble mediators ( .... We have developed a novel animal model by which to study arthritic disease caused by insect-transmitted viruses known as arboviruses. The existence of this model and novel reagents provides an excellent opportunity to further explore the basic mechanisms of infectious disease in a complete functioning animal, rather than specific cultured cells. The study will use modern approaches in molecular and cellular biology to achieve this goal. The production by our immune systems of soluble mediators (cytokines-chemokines) and antibodies is an overwhelming positive aspect of our physiological response to infection by microbes. Protection from disease by these immune compounds can happen naturally, or the body's ability to produce these factors can be exploited to our benefit via the administration of vaccines. However, these factors can also be detrimental to the host contributing to severe disease. For instance, work performed almost 40 years ago showed for the first time that under particular conditions, antibodies against viruses can enhance infection, instead of inhibiting infection as normally seen. In the intervening years work by scientists all over the world has associated antibody-dependent enhancement (ADE) of infection to many types of viruses; ADE is even thought to be a risk factor to serious disease with dengue virus, and has been shown in vitro for the AIDS virus and Ebola virus. We have recently discovered a molecular mechanism which explains how antibody enhances viral infection in vitro. In studies on immune cells infected with Ross River Virus (RRV) we found that infection helped by antibody resulted in the specific disruption to the production of cellular chemicals which are toxic to viruses. Are these mechanisms of antibody-enhanced infection also found in animals? Will such mode of infection cause enhanced disease and tissue pathology (arthritis) in animals?
    Read more Read less
    More information
    Funded Activity

    Assessment Of Interventions For Controlling Pandemic Influenza And Determining Data Needs To Inform These Assessments

    Funder
    National Health and Medical Research Council
    Funding Amount
    $183,040.00
    Summary
    The aim of this study is to help us prepare for a pandemic of influenza by comparing how effective the various available control strategies are at reducing transmission of the disease. The available control interventions include: reducing the number of close contacts we make with others, isolating cases after they are diagnosed, closing schools, quarantining households, quarantining individuals who are known to have been exposed to a case, and using antiviral drugs treat and protect people at ri .... The aim of this study is to help us prepare for a pandemic of influenza by comparing how effective the various available control strategies are at reducing transmission of the disease. The available control interventions include: reducing the number of close contacts we make with others, isolating cases after they are diagnosed, closing schools, quarantining households, quarantining individuals who are known to have been exposed to a case, and using antiviral drugs treat and protect people at risk of being infected. We will compare these control measures by taking due account of the ability and resources available for these interventions, and with regard to the need to maintain essential services. The comparisons will be made using mathematical models that describe the transmission of the infection. All available data and advice from experts will be used to ensure that realistic models are used for the comparisons. We will also use the models to determine the best use of the limited antiviral drugs available, until a vaccine becomes available. We will consider how the control strategy should be changed if a strain develops that is resistant to the antiviral drugs. In addition, we will determine what data need to be collected during the early stages of a pandemic to help us to determine the best use of the antiviral drugs, the best use of a new vaccine and to check on the development of resistance to the antiviral drugs.
    Read more Read less
    More information
    Funded Activity

    The Role Of Capsid Protein Nucleolar Localisation In Chikungunya Virus: Implications For Vaccine Development

    Funder
    National Health and Medical Research Council
    Funding Amount
    $520,520.00
    Summary
    Chikungunya virus (CHIKV) is a globally widespread mosquito-borne alphavirus capable of causing considerable human morbidity and mortality. With no CHIKV vaccine or antiviral available this proposal aims to develop a live attenuated CHIKV vaccine, rationally designed by investigating the host cell nucleolar trafficking of CHIKV capsid protein. This vaccine has the potential to provide cross-protection against additional arthritogenic alphaviruses endemic to Australia such as Ross River virus.
    More information
    Funded Activity

    Novel Insights Into The Mechanisms Of How Viruses Cause Arthritis/Arthralgia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $78,187.00
    Summary
    Viruses cause many diseases today and new viruses emerge to post threats to future health and well being. The proposed work investigates how viruses cause disease in people, particularly how viral infections can lead to arthritis or muscle pain. This understanding will be used in the development of new prevention strategies and treatments.
    More information
    Funded Activity

    The Role Of Duffy And PF4 In The Platelet Killing Of Malaria Parasites.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $350,045.00
    Summary
    Platelets in the blood can kill the Plasmodium parasite, which lives inside red blood cells and causes malaria. Platelets bind parasite-infected red cells and release a molecule that is toxic to the parasite. This project will study why a red cell molecule called Duffy is also needed for this function of platelets. Most Africans carry a gene for Duffy that stops its expression in red cells, and may therefore be more susceptible to malaria because their platelets cannot kill the malaria parasite.
    More information
    Funded Activity

    Mechanisms Of Induction And Progression Of Childhood Asthma: Investigations In A Mouse Model

    Funder
    National Health and Medical Research Council
    Funding Amount
    $517,586.00
    Summary
    This project investigates how certain respiratory viral infections in very young children might predispose to developing asthma, and how inflammation in the airways in asthma might then worsen. The experimental work, which will use unique mouse models developed in the laboratories of the chief investigators, will focus on changes in genes that control the pattern of immune response to allergens and that regulate the progression of inflammation.
    More information
    Funded Activity

    Spatio-temporal Dynamics Of Arbovirus Infection

    Funder
    National Health and Medical Research Council
    Funding Amount
    $491,504.00
    Summary
    Mosquito-borne alphaviruses such as Ross River and chikungunya viruses cause widespread epidemics and exert extreme pressure on the public health systems of affected regions. Alphaviruses spreads to joints and triggers a severe disease in those affected. There are no effective treatments or vaccines. The project will investigate virus-host interaction at the bite site. The outcome will be new knowledge to treat infection at the mosquito bite site to prevent joint disease.
    More information
    Funded Activity

    Integrated Chikungunya Research

    Funder
    National Health and Medical Research Council
    Funding Amount
    $514,806.00
    More information
    Funded Activity

    Novel Insights Into The Pathobiology Of Alphavirus Infections

    Funder
    National Health and Medical Research Council
    Funding Amount
    $827,660.00
    Summary
    Infections with mosquito-borne viruses are increasing at an alarming rate worldwide. Ross River virus is endemic in parts of Australia, PNG and Pacific islands, while chikungunya virus is distributed globally and causes recurrent pandemics that involve millions of people. These viruses cause severe musculoskeletal disease for several months after infection. This project aims to establish how these viruses interact with the human host to cause disease and may provide a basis for new treatments.
    More information

    Showing 1-10 of 17 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback